EntrezGene:55671

Symbol:	SMEK1
Description:	SMEK homolog 1, suppressor of mek1 (Dictyostelium)
Synonyms:	FLFL1, KIAA2010, PP4R3A, smk-1, smk1
Species:	Human (Homo sapiens)
Xrefs:	EntrezGene:55671 HGNC:20219 MIM:610351 Ensembl:ENSG00000100796 HPRD:11176 Vega:OTTHUMG00000171102 EpiFactors:55671
Associated motifs:	NA
Transcripton Factor?:	No

TSS regions

---

Copy Excel CSV PDF

Show 102550All entries

Search:

Hg19::chr14:91932629..91932652,-	p14@SMEK1
Hg19::chr14:91976607..91976661,-	p1@SMEK1
Hg19::chr14:91976671..91976682,-	p6@SMEK1
Hg19::chr14:91976754..91976766,-	p4@SMEK1
Hg19::chr14:91976773..91976785,-	p5@SMEK1
Hg19::chr14:91976794..91976871,-	p2@SMEK1
Hg19::chr14:91976874..91976905,-	p3@SMEK1
TSS peak ID	Short_description

Showing 1 to 7 of 7 entries

Previous1Next

View on UCSC genome browser

---

Mouse over to see Genome browser image, Click image to go to Genome browser

TSS expression

---

Copy Excel CSV PDF

Search:

Sample	p1@SMEK1	p2@SMEK1	p3@SMEK1	p4@SMEK1	p5@SMEK1

Sample	p1@SMEK1	p2@SMEK1	p3@SMEK1	p4@SMEK1	p5@SMEK1
CD8+ T Cells, donor2.CNhs11956.11307-117C2	101.09	42.52	16.05	5.08	3.74
salivary acinar cells, donor3.CNhs12812.11773-123I9	94.70	16.59	4.84	0.69	1.38
hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3	86.21	9.32	2.33	0.00	1.16
tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1	83.02	3.86	1.93	1.93	0.00
Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3	82.77	14.44	3.85	1.92	0.96
CD4+ T Cells, donor1.CNhs10853.11225-116C1	81.04	67.86	13.38	5.70	4.92
acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1	80.36	11.28	1.41	0.00	1.41
stomach, fetal, donor1.CNhs11771.10062-101H8	78.88	5.84	2.19	0.00	2.19
neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8	78.77	6.15	1.12	1.12	0.00
CD8+ T Cells, donor3.CNhs11999.11383-118B6	76.32	40.55	16.37	4.06	3.62
CD19+ B Cells, donor2.CNhs12352.11624-122B4	75.75	45.80	19.38	4.70	3.52
CD19+ B Cells, donor1.CNhs12343.11544-120B5	75.71	59.77	23.91	3.98	5.12
CD34+ Progenitors, donor2.CNhs12205.11625-122B5	75.67	14.57	10.65	0.56	3.92
CD8+ T Cells, donor1.CNhs10854.11226-116C2	74.19	48.79	12.90	6.05	3.83
CD4+ T Cells, donor2.CNhs11955.11306-117C1	73.49	57.38	18.47	7.07	4.72
CD14+ Monocytes, donor2.CNhs11954.11305-117B9	73.00	37.10	18.25	8.62	3.41
Natural Killer Cells, donor2.CNhs11957.11311-117C6	71.16	38.81	12.72	3.23	3.45
osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6	70.42	10.36	2.76	0.00	1.38
CD19+ B Cells, donor3.CNhs12354.11705-123B4	68.43	50.08	19.88	8.41	4.97
Natural Killer Cells, donor3.CNhs12001.11387-118C1	68.41	46.59	11.29	3.85	4.11
Dendritic Cells - plasmacytoid, donor3.CNhs12200.11385-118B8	67.61	11.52	7.06	0.00	1.11
Dendritic Cells - plasmacytoid, donor2.CNhs12196.11309-117C4	67.50	7.44	4.00	0.57	0.00
Myoblast differentiation to myotubes, day00, control donor1.CNhs13847.13469-144I4	67.04	2.85	2.85	0.00	1.43
embryonic pancreas cell line:2C6.CNhs11814.10603-108E9	66.90	14.34	4.78	0.00	0.00
skeletal muscle - soleus muscle, donor1.CNhs13454.10282-104F3	66.69	5.18	1.29	0.00	0.00
Natural Killer Cells, donor1.CNhs10859.11230-116C6	66.01	43.94	11.23	6.30	3.55
rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9	64.68	4.17	1.39	0.35	0.17
Dendritic Cells - plasmacytoid, donor1.CNhs10857.11228-116C4	62.48	10.49	7.39	0.95	0.95
CD14+ Monocytes, donor3.CNhs11997.11381-118B4	62.07	40.36	10.63	6.94	4.77
acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8	61.54	16.00	4.92	2.46	0.00
bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1	61.05	11.99	3.94	0.36	0.90
embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1	60.48	15.29	2.66	0.66	0.00
CD14+ Monocytes, donor1.CNhs10852.11224-116B9	59.28	28.25	14.40	6.65	4.43
Basophils, donor2.CNhs12563.12242-129H1	58.34	34.54	7.68	3.07	2.69
malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7	58.09	5.75	3.83	0.64	0.00
CD4+ T Cells, donor3.CNhs11998.11382-118B5	57.36	62.30	6.99	8.43	5.76
neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4	54.74	6.52	1.92	0.00	0.38
cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2	52.19	11.27	1.78	2.08	0.59
embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3	51.80	18.21	4.71	0.00	0.63
thymus, adult, pool1.CNhs10633.10027-101D9	51.41	20.41	2.78	0.65	0.65
Peripheral Blood Mononuclear Cells, donor3.CNhs12002.11388-118C2	50.70	58.27	10.57	6.08	5.44
thymus, fetal, pool1.CNhs10650.10043-101F7	50.59	15.39	2.67	0.81	0.74
breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5	50.38	12.77	1.75	1.75	1.84
heart - tricuspid valve, adult.CNhs12857.10207-103F9	50.25	11.49	3.59	1.44	2.15
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8	49.51	6.53	3.84	0.58	0.38
gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9	49.13	11.67	3.31	1.44	0.86
small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4	49.06	4.08	2.42	0.15	0.15
glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4	48.79	13.43	2.83	0.71	1.41
neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7	48.47	5.53	2.13	1.49	0.21
myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6	48.24	11.35	3.97	0.57	0.00
sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2	48.10	6.41	0.00	0.80	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7	47.95	20.74	7.18	0.55	0.47
immature langerhans cells, donor1.CNhs13537.11904-125F5	47.69	19.35	5.85	3.15	1.80
cerebellum, adult, donor10252.CNhs12323.10166-103B4	47.33	23.77	1.66	1.22	0.77
Cardiac Myocyte, donor1.CNhs12341.11525-119I4	46.32	7.31	2.44	2.44	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6	46.24	8.32	3.84	0.64	0.28
granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7	45.99	24.27	12.77	3.83	3.83
Mast cell, donor2.CNhs12594.11565-120D8	45.82	25.29	2.07	1.87	1.24
Mast cell, donor3.CNhs12593.11566-120D9	44.97	24.36	6.49	2.02	1.44
mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1	44.80	12.47	1.90	0.00	0.85
Basophils, donor3.CNhs12575.12243-129H2	44.74	27.56	4.64	4.18	3.25
vagina, adult.CNhs12854.10204-103F6	44.61	11.32	1.33	0.67	0.00
Basophils, donor1.CNhs12546.12241-129G9	43.27	26.36	7.47	3.15	2.36
Mast cell, donor4.CNhs12592.11567-120E1	43.17	30.30	2.40	1.77	2.15
Hepatocyte, donor1.CNhs12340.11523-119I2	43.10	15.21	2.54	5.07	0.00
Neural stem cells, donor2.CNhs11384.11352-117H2	42.95	15.62	3.90	0.00	2.60
Small Airway Epithelial Cells, donor3.CNhs12016.11406-118E2	42.69	11.03	2.12	1.92	1.01
squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4	42.67	11.61	6.25	0.71	0.71
medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1	42.06	13.00	4.29	0.55	0.97
anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4	41.80	11.61	1.48	0.84	0.63
mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8	41.39	11.37	1.29	2.57	1.29
rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4	41.38	5.70	2.09	0.58	0.70
Hepatocyte, donor3.CNhs12626.11684-122I1	41.36	14.77	1.77	0.59	0.59
Peripheral Blood Mononuclear Cells, donor1.CNhs10860.11231-116C7	41.15	48.80	6.82	5.58	3.10
small intestine, fetal, donor1.CNhs11773.10064-101I1	41.09	6.34	2.40	1.09	0.22
CD34+ Progenitors, donor1.CNhs13227.11545-120B6	40.97	7.93	6.61	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2	40.10	15.04	2.51	0.00	2.51
CD14+ monocytes - treated with IFN + N-hexane, donor2.CNhs13476.11871-125B8	40.09	50.66	10.57	8.78	6.58
CD4+CD25+CD45RA+ naive regulatory T cells, donor1.CNhs13238.11780-124A7	40.09	38.78	7.50	6.19	8.15
gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2	39.89	14.28	2.15	3.13	1.37
small intestine, adult, pool1.CNhs10630.10024-101D6	39.59	12.73	1.39	1.23	1.00
retinoblastoma cell line:Y79.CNhs11267.10475-106I7	39.50	4.74	0.63	0.79	0.32
testis, adult, pool2.CNhs12998.10096-102C6	39.39	9.91	10.99	1.34	0.54
CD14+ monocytes - treated with BCG, donor2.CNhs13475.11870-125B7	38.94	55.84	15.11	5.64	6.66
lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4	38.67	7.36	1.20	0.17	0.68
merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6	38.40	8.90	4.22	0.00	0.94
rectum, fetal, donor1.CNhs11777.10067-101I4	37.44	11.87	2.74	0.91	0.91
CD14+ monocytes - treated with Salmonella, donor3.CNhs13493.11886-125D5	37.37	36.12	10.59	4.98	3.11
adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9	37.26	15.41	5.70	1.09	1.21
parietal lobe, adult, donor10252.CNhs12317.10157-103A4	37.00	11.78	1.86	1.03	0.21
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1.CNhs13467.11862-125A8	36.93	58.54	13.82	11.05	6.03
CD14+ monocytes - treated with Salmonella, donor2.CNhs13485.11876-125C4	36.88	36.88	14.18	3.40	0.57
bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2	36.68	4.45	2.22	0.00	0.00
cerebellum - adult, donor10196.CNhs13799.10173-103C2	36.62	19.84	1.53	3.05	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2.CNhs13483.11872-125B9	36.50	47.45	11.99	9.91	7.30
duodenum, fetal, donor1, tech_rep2.CNhs12997.10071-101I8	36.50	12.70	4.23	0.53	0.53
CD4+CD25+CD45RA+ naive regulatory T cells, donor2.CNhs13235.11796-124C5	36.46	46.87	12.78	7.10	4.26
thyroid, fetal, donor1.CNhs11769.10060-101H6	36.38	10.31	2.02	0.20	0.81
choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6	36.20	28.36	10.61	2.08	0.69
CD14+ monocytes - treated with B-glucan, donor2.CNhs13489.11879-125C7	36.18	40.71	8.63	3.29	1.64
lung, fetal, donor1.CNhs11680.10068-101I5	36.00	10.85	2.04	0.63	1.10
colon, adult, pool1.CNhs10619.10014-101C5	35.83	10.08	2.12	0.71	1.24
Reticulocytes, biol_rep2.CNhs13553.11932-125I6	35.82	10.46	1.31	1.57	0.78
uterus, adult, pool1.CNhs11676.10100-102D1	35.82	12.59	2.32	0.37	0.73
bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9	35.68	9.35	3.06	0.36	1.17
Peripheral Blood Mononuclear Cells, donor2.CNhs11958.11312-117C7	35.59	33.22	9.71	4.31	4.10
pituitary gland, adult, donor10252.CNhs12229.10162-103A9	35.52	13.20	2.96	0.46	0.46
merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7	35.51	12.17	3.77	0.72	1.16
mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3	35.33	5.05	0.00	0.00	0.00
Reticulocytes, biol_rep1.CNhs13552.11931-125I5	35.30	9.65	0.44	1.53	1.53
heart, fetal, pool1.CNhs10653.10046-101G1	35.27	8.60	1.61	0.40	0.34
middle temporal gyrus, donor10252.CNhs12316.10156-103A3	35.26	13.27	1.38	0.69	0.41
carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3	35.25	6.25	2.60	0.87	0.35
CD14+ monocytes - treated with B-glucan, donor3.CNhs13495.11889-125D8	35.00	39.33	5.57	2.79	2.48
temporal lobe, fetal, donor1, tech_rep1.CNhs11772.10063-101H9	34.91	9.60	0.87	0.00	0.00
occipital cortex, adult, donor10252.CNhs12320.10163-103B1	34.32	13.89	2.39	0.80	0.48
Small Airway Epithelial Cells, donor2.CNhs11975.11334-117F2	34.21	8.65	2.50	1.35	1.15
cervical cancer cell line:ME-180.CNhs11289.10553-107I4	34.16	12.83	2.93	1.25	0.84
throat, fetal, donor1.CNhs11770.10061-101H7	34.04	6.43	3.09	0.48	0.48
epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3	34.00	9.21	2.94	2.16	0.88
CD14+ monocytes - treated with lipopolysaccharide, donor2.CNhs13533.11875-125C3	33.88	23.57	10.31	3.31	1.84
pineal gland - adult, donor10196.CNhs13804.10179-103C8	33.75	4.82	1.07	0.00	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1	33.67	7.22	5.11	0.60	0.90
squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4	33.53	4.94	3.88	1.41	1.06
Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6	33.43	12.00	2.94	1.91	0.77
osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9	33.42	13.33	5.17	0.99	0.40
neuroblastoma cell line:NH-12.CNhs11811.10555-107I6	33.20	10.48	3.71	0.44	0.44
appendix, adult.CNhs12842.10189-103D9	33.15	22.66	3.32	0.55	0.83
ductus deferens, adult.CNhs12846.10196-103E7	33.15	13.02	0.39	0.79	0.39
testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5	33.09	17.55	6.02	0.75	1.00
seminal vesicle, adult.CNhs12851.10201-103F3	33.02	20.75	2.12	1.27	1.69
Mast cell - stimulated, donor1.CNhs11073.11487-119E2	33.01	1.48	0.49	0.49	0.00
CD19+ B Cells (pluriselect), donor090309, donation3.CNhs12181.12199-129C3	32.91	32.02	6.23	0.00	1.78
diaphragm, fetal, donor1.CNhs11779.10069-101I6	32.91	9.63	0.80	0.00	1.61
cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3	32.87	7.66	1.98	0.99	0.99
CD14+ monocytes - treated with IFN + N-hexane, donor1.CNhs13466.11861-125A7	32.66	66.96	11.54	8.91	4.62
occipital cortex - adult, donor10196.CNhs13798.10172-103C1	32.59	8.50	1.42	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7	32.43	12.53	3.58	0.40	1.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6	32.38	13.45	5.77	0.88	0.37
testis, adult, pool1.CNhs10632.10026-101D8	32.36	9.02	5.53	0.30	0.53
aorta, adult, pool1.CNhs11760.10052-101G7	32.08	10.56	1.20	0.80	0.20
amygdala, adult, donor10252.CNhs12311.10151-102I7	32.07	14.21	2.11	1.13	0.70
epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8	32.04	14.36	6.09	0.61	1.31
Neurons, donor3.CNhs13815.11655-122E8	31.90	5.74	1.28	0.00	0.00
immature langerhans cells, donor2.CNhs13480.11905-125F6	31.73	27.08	6.19	6.19	0.77
Smooth Muscle Cells - Bronchial, donor2.CNhs12348.11592-120G8	31.67	6.85	0.43	0.43	0.43
Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8	31.56	9.53	3.41	0.28	0.14
oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4	31.54	4.39	2.66	0.58	0.69
CD19+ B Cells (pluriselect), donor090612, donation3.CNhs12188.12214-129D9	31.48	29.58	2.86	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1.CNhs10612.10007-101B4	31.44	15.82	1.69	1.51	0.75
pineal gland, adult, donor10252.CNhs12228.10160-103A7	31.27	16.48	1.68	0.67	0.00
cervix, adult, pool1.CNhs10618.10013-101C4	31.16	12.16	2.15	0.62	0.69
Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8	30.75	15.96	7.44	1.24	0.85
CD4+CD25-CD45RA+ naive conventional T cells, donor1.CNhs13223.11784-124B2	30.70	44.78	8.01	4.00	1.04
CD14+ monocytes - treated with IFN + N-hexane, donor3.CNhs13490.11881-125C9	30.69	54.98	9.80	7.67	5.11
gall bladder, adult.CNhs12848.10198-103E9	30.52	18.57	1.07	1.71	0.85
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3.CNhs13544.11882-125D1	30.41	39.53	12.16	6.08	4.78
testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8	30.33	44.11	9.74	3.95	3.86
small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1	30.27	8.92	5.08	0.79	0.56
CD14+ monocytes - treated with Group A streptococci, donor2.CNhs13532.11874-125C2	30.17	29.20	6.74	2.25	1.28
breast carcinoma cell line:MCF7.CNhs11943.10482-107A5	29.95	38.80	4.95	3.13	3.39
colon, fetal, donor1.CNhs11780.10070-101I7	29.94	6.72	1.22	0.61	1.22
CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2	29.92	35.20	5.28	0.00	0.00
endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2	29.88	5.41	2.28	0.28	0.57
CD4+CD25-CD45RA- memory conventional T cells, donor3.CNhs13539.11909-125G1	29.86	30.11	4.55	2.28	1.01
CD14+ monocytes - treated with Candida, donor3.CNhs13494.11888-125D7	29.79	41.98	5.42	0.00	2.71
serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9	29.78	12.37	2.06	0.46	0.69
leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1	29.75	6.10	1.53	1.27	1.53
hippocampus, adult, donor10252.CNhs12312.10153-102I9	29.69	15.12	1.36	0.82	0.95
SABiosciences XpressRef Human Universal Total RNA, pool1.CNhs10610.10002-101A5	29.57	14.22	2.06	1.75	0.72
heart - pulmonic valve, adult.CNhs12856.10206-103F8	29.56	11.00	1.83	0.92	0.23
CD4+CD25-CD45RA- memory conventional T cells, donor1.CNhs13239.11786-124B4	29.51	38.71	5.75	2.68	3.45
occipital lobe, fetal, donor1.CNhs11784.10073-102A1	29.49	11.09	3.78	0.50	0.25
Hepatocyte, donor2.CNhs12349.11603-120I1	29.48	5.90	0.98	0.98	0.98
caudate nucleus, adult, donor10252.CNhs12321.10164-103B2	29.43	10.13	2.29	1.45	0.24
Neurons, donor1.CNhs12338.11494-119E9	29.38	6.96	1.55	0.77	1.55
pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3	29.26	7.28	2.68	0.77	0.51
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3	29.15	16.58	4.84	1.07	0.99
Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3	29.14	8.83	4.86	0.88	0.88
parietal lobe, fetal, donor1.CNhs11782.10072-101I9	28.99	10.94	3.28	0.55	0.00
CD19+ B Cells (pluriselect), donor090325, donation2.CNhs12175.12174-128I5	28.83	34.43	3.20	0.80	0.80
papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3	28.83	8.58	2.81	0.44	0.74
adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4	28.82	7.86	1.12	0.75	0.19
kidney, fetal, pool1.CNhs10652.10045-101F9	28.75	9.60	1.78	0.16	0.16
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4	28.73	17.16	4.72	1.18	0.71
smooth muscle, adult, pool1.CNhs11755.10048-101G3	28.68	11.28	1.47	0.00	0.25
placenta, adult, pool1.CNhs10627.10021-101D3	28.56	16.14	2.84	0.80	0.71
CD14+ monocyte derived endothelial progenitor cells, donor2.CNhs11897.11310-117C5	28.50	13.93	2.59	0.32	0.32
Neural stem cells, donor1.CNhs11063.11275-116H6	28.46	9.15	1.78	0.51	0.51
chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4	28.45	17.17	6.36	0.79	0.79
kidney, adult, pool1.CNhs10622.10017-101C8	28.45	9.06	1.65	0.63	1.18
CD19+ B Cells (pluriselect), donor090309, donation2.CNhs12179.12194-129B7	28.40	27.85	2.73	1.64	1.09
CD14+ monocytes - treated with BCG, donor3.CNhs13543.11880-125C8	28.38	40.20	10.64	5.44	4.73
neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6	28.38	4.21	1.12	0.74	0.50
acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6	28.31	10.99	4.66	0.33	1.00
Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1	28.29	7.41	3.14	0.67	0.67
schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1	28.28	6.86	1.77	0.83	0.00
heart - mitral valve, adult.CNhs12855.10205-103F7	28.21	12.85	1.95	0.84	0.56
medial temporal gyrus, adult, donor10252.CNhs12310.10150-102I6	28.17	15.65	1.13	0.88	0.63
epididymis, adult.CNhs12847.10197-103E8	28.13	9.09	2.80	0.52	0.35
vein, adult.CNhs12844.10191-103E2	27.98	18.32	3.02	0.81	0.60
CD14+ monocytes - treated with BCG, donor1.CNhs13465.11860-125A6	27.91	42.58	12.08	10.93	8.34
duodenum, fetal, donor1, tech_rep1.CNhs11781.10071-101I8	27.83	10.89	2.42	0.00	0.00
b cell line:RPMI1788.CNhs10744.10427-106D4	27.82	14.28	4.43	0.49	0.98
Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4	27.76	4.48	1.07	1.07	0.72
trachea, fetal, donor1.CNhs11766.10058-101H4	27.61	9.31	1.66	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2.CNhs12996.10063-101H9	27.55	6.43	2.45	0.61	0.00
bladder, adult, pool1.CNhs10616.10011-101C2	27.52	12.13	1.78	0.69	0.30
squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9	27.52	8.91	1.44	0.32	0.64
parietal lobe - adult, donor10196.CNhs13797.10171-103B9	27.34	10.94	1.56	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2.CNhs13205.11795-124C4	27.29	48.16	5.62	1.87	3.48
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9	27.28	7.66	3.71	1.24	0.82
schwannoma cell line:HS-PSS.CNhs11183.10442-106F1	27.27	8.35	1.87	0.60	0.68
Dendritic Cells - monocyte immature derived, donor1, tech_rep1.CNhs10855.11227-116C3	27.26	5.19	0.65	0.65	1.30
ovary, adult, pool1.CNhs10626.10020-101D2	27.23	7.52	1.43	0.38	0.75
prostate cancer cell line:DU145.CNhs11260.10490-107B4	27.07	11.94	4.96	0.24	0.83
CD14+ monocytes - treated with lipopolysaccharide, donor3.CNhs13545.11885-125D4	26.90	24.37	6.33	0.95	1.27
hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1	26.81	10.25	4.47	0.79	1.31
endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7	26.76	5.96	1.53	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0).CNhs12825.12725-135G7	26.74	16.17	8.29	0.62	0.93
cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8	26.73	7.94	1.78	0.73	0.73
teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6	26.73	14.70	7.60	0.63	1.14
CD14+ monocytes - mock treated, donor3.CNhs13491.11883-125D2	26.68	52.16	8.25	1.46	2.67
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9	26.68	8.32	2.29	0.57	0.00
ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6	26.61	12.13	6.46	2.35	1.96
Mast cell, donor1.CNhs12566.11563-120D6	26.59	16.91	1.67	0.79	0.53
gastric cancer cell line:AZ521.CNhs11286.10549-107H9	26.46	6.76	3.67	0.80	0.69
pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5	26.45	39.55	9.43	3.93	3.14
mesothelioma cell line:Mero-82.CNhs13069.10853-111F7	26.43	5.87	2.69	0.49	0.73
melanoma cell line:COLO 679.CNhs11281.10514-107E1	26.39	6.98	1.36	0.91	0.61
tonsil, adult, pool1.CNhs10654.10047-101G2	26.33	19.13	1.48	1.08	0.61
Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3	26.28	7.73	1.80	0.26	0.52
embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2	26.15	9.93	3.64	0.33	0.00
globus pallidus, adult, donor10252.CNhs12319.10161-103A8	26.15	16.43	1.78	0.68	0.27
prostate, adult, pool1.CNhs10628.10022-101D4	26.14	12.09	1.73	0.31	0.24
spinal cord, adult, donor10252.CNhs12227.10159-103A6	26.14	18.12	1.19	0.30	0.59
Clontech Human Universal Reference Total RNA, pool1.CNhs10608.10000-101A1	26.13	8.91	3.67	0.52	0.59
acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8	25.98	11.92	5.54	0.85	0.00
osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2	25.93	9.15	1.14	1.14	0.38
CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9	25.73	39.54	7.85	4.06	1.35
signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4	25.72	2.94	0.98	0.20	0.20
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5	25.67	3.83	1.59	0.96	0.48
CD8+ T Cells (pluriselect), donor090325, donation1.CNhs12201.12148-128F6	25.60	36.74	3.61	0.90	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0).CNhs12952.12858-137D5	25.50	8.17	3.38	0.25	0.58
Dendritic Cells - monocyte immature derived, donor1, tech_rep2.CNhs11062.11227-116C3	25.42	6.79	0.52	0.17	0.70
Wilms' tumor cell line:G-401.CNhs11892.10809-111A8	25.42	6.09	2.24	0.64	0.32
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1	25.41	10.65	3.10	1.01	0.74
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7	25.37	9.69	3.70	0.74	0.74
CD4+CD25+CD45RA+ naive regulatory T cells, donor3.CNhs13513.11907-125F8	25.33	35.07	9.74	5.84	1.95
myeloma cell line:PCM6.CNhs11258.10474-106I6	25.32	26.52	2.41	0.86	0.52
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2	25.29	16.73	4.36	1.22	1.15
CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1	25.25	9.69	5.87	0.00	0.59
Prostate Epithelial Cells, donor3.CNhs12014.11404-118D9	25.23	17.31	3.31	2.21	1.29
argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4	25.19	9.83	4.28	0.25	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0).CNhs12859.12760-136B6	25.18	9.34	4.03	0.64	0.64
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8	25.13	9.14	3.62	1.02	0.79
CD8+ T Cells (pluriselect), donor090612, donation2.CNhs12184.12206-129D1	25.10	31.73	2.60	0.95	1.18
CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9	25.04	42.72	5.30	4.12	4.71
signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6	24.99	6.58	1.46	1.22	0.49
CD14+ monocytes - treated with Group A streptococci, donor3.CNhs13492.11884-125D3	24.93	34.52	9.59	6.39	2.56
neuroblastoma cell line:NB-1.CNhs11284.10539-107G8	24.91	11.65	2.59	0.86	0.54
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5	24.87	11.13	3.48	0.58	0.39
transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4	24.83	12.70	3.01	0.98	0.81
CD14+ monocytes - treated with lipopolysaccharide, donor1.CNhs13470.11865-125B2	24.82	24.22	4.24	0.00	1.21
diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1	24.81	9.85	5.84	0.55	1.09
penis, adult.CNhs12850.10200-103F2	24.81	10.42	0.99	0.00	0.50
adipose tissue, adult, pool1.CNhs10615.10010-101C1	24.76	10.84	1.47	0.44	0.44
CD4+CD25-CD45RA- memory conventional T cells, donor2.CNhs13237.11798-124C7	24.74	30.24	5.50	1.03	1.72
putamen, adult, donor10196.CNhs12324.10176-103C5	24.67	12.26	2.83	0.47	0.31
Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5	24.66	8.45	2.82	0.68	0.79
CD8+ T Cells (pluriselect), donor090612, donation3.CNhs12187.12211-129D6	24.63	29.56	2.46	0.00	0.82
CD14+ monocytes - treated with Candida, donor2.CNhs13488.11878-125C6	24.53	34.21	10.33	4.52	2.58
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2	24.53	9.20	2.04	1.02	1.02
liver, adult, pool1.CNhs10624.10018-101C9	24.47	5.86	1.76	0.88	0.88
CD8+ T Cells (pluriselect), donor090325, donation2.CNhs12199.12171-128I2	24.45	28.80	2.82	0.64	1.28
CD14+ monocytes - mock treated, donor1.CNhs13468.11863-125A9	24.43	47.69	7.56	2.91	1.45
bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7	24.41	10.93	3.81	0.51	0.00
CD19+ B Cells (pluriselect), donor090325, donation1.CNhs12531.12151-128F9	24.32	40.11	8.11	0.00	1.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6	24.32	6.13	3.45	0.19	0.38
throat, adult.CNhs12858.10209-103G2	24.31	14.29	1.28	1.71	0.43
Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2	24.29	8.46	2.05	0.73	0.60
nasal epithelial cells, donor2.CNhs12574.12227-129F4	24.26	4.35	1.24	1.87	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1	24.24	6.70	5.12	0.24	0.37
pancreas, adult, donor1.CNhs11756.10049-101G4	24.23	10.16	0.78	0.78	0.00
Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9	24.14	7.76	0.84	0.34	1.01
olfactory region, adult.CNhs12611.10195-103E6	24.06	9.85	1.94	0.81	0.32
chorionic membrane cells, donor1.CNhs12504.12238-129G6	23.93	10.53	1.60	0.32	0.32
Skeletal Muscle Cells, donor1.CNhs11083.11281-116I3	23.88	5.80	1.55	0.29	0.29
trachea, adult, pool1.CNhs10635.10029-101E2	23.88	12.91	1.22	0.72	0.72
small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5	23.86	4.18	2.20	0.55	0.44
lymph node, adult, donor1.CNhs11788.10077-102A5	23.82	19.85	2.98	1.49	0.00
Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3	23.81	3.50	0.82	0.31	0.21
CD8+ T Cells (pluriselect), donor090309, donation3.CNhs12180.12196-129B9	23.76	21.86	2.85	0.00	0.95
tongue, adult.CNhs12853.10203-103F5	23.73	13.50	3.48	1.31	0.22
medulla oblongata, adult, donor10252.CNhs12315.10155-103A2	23.63	15.53	1.89	1.00	0.55
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5	23.60	6.32	3.16	0.37	0.37
lung, adult, pool1.CNhs10625.10019-101D1	23.60	15.16	1.17	0.75	0.75
pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3	23.60	12.10	3.43	1.01	1.01
spleen, fetal, pool1.CNhs10651.10044-101F8	23.59	16.63	3.35	0.45	0.71
parotid gland, adult.CNhs12849.10199-103F1	23.58	17.54	2.19	1.64	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1.CNhs10858.11229-116C5	23.51	20.38	3.58	0.45	0.22
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9	23.50	8.43	2.51	0.54	0.18
heart, adult, pool1.CNhs10621.10016-101C7	23.43	9.60	1.34	0.45	0.89
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6	23.41	7.20	0.60	0.30	0.30
submaxillary gland, adult.CNhs12852.10202-103F4	23.40	19.73	2.29	0.92	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5	23.39	18.18	5.03	1.59	0.97
substantia nigra, adult, donor10252.CNhs12318.10158-103A5	23.36	18.06	2.44	0.29	0.29
carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8	23.33	8.16	4.08	0.87	1.17
cerebral meninges, adult.CNhs12840.10188-103D8	23.25	7.90	0.44	0.44	0.44
Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4	23.24	10.82	2.34	0.74	0.86
large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5	23.23	10.24	5.07	0.42	0.63
CD14+ monocytes - treated with Salmonella, donor1.CNhs13471.11866-125B3	23.22	40.63	9.87	3.19	2.03
anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5	23.15	3.45	1.22	0.22	0.11
acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7	23.11	9.47	2.78	0.56	1.11
Fibroblast - Aortic Adventitial, donor3.CNhs12011.11401-118D6	23.05	7.09	1.06	0.71	1.06
serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9	22.93	11.52	3.58	1.57	1.12
chorionic membrane cells, donor3.CNhs12380.12240-129G8	22.92	14.39	5.86	0.53	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3	22.89	32.51	3.77	2.47	1.95
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9	22.89	23.47	3.77	0.29	0.58
Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1	22.89	8.20	2.59	0.22	0.86
colon, adult, donor1.CNhs11794.10082-102B1	22.89	14.93	1.00	1.99	2.99
skeletal muscle, adult, pool1.CNhs10629.10023-101D5	22.89	4.21	0.62	0.31	0.00
salivary acinar cells, donor2.CNhs12811.11772-123I8	22.88	13.32	2.73	2.39	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3	22.79	12.70	6.78	0.58	0.87
liposarcoma cell line:SW 872.CNhs11851.10726-110A6	22.78	7.25	4.19	0.11	0.45
cerebellum, adult, pool1.CNhs11795.10083-102B2	22.76	16.85	2.36	1.48	2.07
transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6	22.73	8.22	5.12	0.21	0.53
plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3	22.70	10.72	2.77	0.46	0.46
amniotic membrane cells, donor1.CNhs12502.12235-129G3	22.68	21.01	1.67	1.91	1.43
CD14+ monocytes - mock treated, donor2.CNhs13484.11873-125C1	22.67	46.48	9.45	2.65	1.89
mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1	22.62	3.19	1.43	0.16	0.32
spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8	22.60	4.93	1.19	0.17	0.85
Fibroblast - Gingival, donor4 (GFH2).CNhs10848.11222-116B7	22.57	7.13	0.00	1.19	0.00
spleen, adult, pool1.CNhs10631.10025-101D7	22.56	19.27	3.57	0.38	0.38
CD14+ monocytes - treated with B-glucan, donor1.CNhs13474.11869-125B6	22.55	51.60	9.76	2.56	1.16
Fibroblast - Gingival, donor3.CNhs12006.11394-118C8	22.53	5.27	1.34	0.41	0.72
CD19+ B Cells (pluriselect), donor090612, donation2.CNhs12185.12209-129D4	22.48	31.07	5.95	1.32	0.66
CD14+ monocyte derived endothelial progenitor cells, donor3.CNhs11904.11386-118B9	22.41	17.77	2.32	0.00	0.26
lung, right lower lobe, adult, donor1.CNhs11786.10075-102A3	22.37	13.67	2.49	0.83	1.24
Neurons, donor2.CNhs12726.11574-120E8	22.28	8.38	3.85	0.34	0.50
small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8	22.22	10.76	5.38	0.70	0.00
prostate cancer cell line:PC-3.CNhs11243.10439-106E7	22.14	7.23	2.45	0.22	0.33
H9 Embryonic Stem cells, biol_rep3 (H9ES-3).CNhs12837.12822-136I5	22.13	20.81	9.41	1.06	0.66
astrocytoma cell line:TM-31.CNhs10742.10425-106D2	22.09	3.07	2.45	0.20	0.10
ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2	22.09	7.53	3.40	0.97	1.21
CD4+CD25-CD45RA+ naive conventional T cells, donor3.CNhs13512.11906-125F7	21.95	31.36	8.36	3.14	1.05
dura mater, adult, donor1.CNhs10648.10041-101F5	21.93	12.95	1.39	0.57	0.51
Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2	21.90	9.99	1.92	0.96	0.55
locus coeruleus - adult, donor10196.CNhs13808.10182-103D2	21.85	6.72	1.29	0.26	0.26
CD19+ B Cells (pluriselect), donor090612, donation1.CNhs12183.12204-129C8	21.84	29.89	5.17	0.57	0.00
CD14+ monocytes - treated with Cryptococcus, donor2.CNhs13487.11877-125C5	21.83	37.66	7.64	2.18	0.55
CD14+ monocytes - treated with Group A streptococci, donor1.CNhs13469.11864-125B1	21.73	37.34	7.65	3.98	2.75
Dendritic Cells - monocyte immature derived, donor3.CNhs12000.11384-118B7	21.67	11.83	0.80	1.86	0.66
CD8+ T Cells (pluriselect), donor090309, donation1.CNhs12176.12186-129A8	21.66	34.72	4.14	0.64	0.00
Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5	21.65	7.63	2.13	0.50	0.50
Urothelial cells, donor0.CNhs10843.11216-116B1	21.59	8.96	1.15	0.69	0.23
oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1	21.59	8.49	2.36	0.59	0.71
splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1	21.59	14.29	4.00	1.80	1.30
blood, adult, pool1.CNhs11761.10053-101G8	21.55	31.13	9.58	4.79	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3	21.51	8.30	4.92	0.31	0.61
H9 Embryonic Stem cells, biol_rep2 (H9ES-2).CNhs12824.12724-135G6	21.47	22.57	11.10	1.22	0.61
Mesenchymal Stem Cells - adipose, donor1.CNhs11345.11537-120A7	21.46	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2.CNhs11671.12180-129A2	21.41	35.17	4.59	3.82	1.53
CD14+ monocytes - treated with Candida, donor1.CNhs13473.11868-125B5	21.37	37.92	5.52	1.72	2.76
Fibroblast - Dermal, donor4.CNhs12052.11450-119A1	21.37	8.69	2.47	0.82	0.94
CD14+ monocytes - treated with Cryptococcus, donor3.CNhs13546.11887-125D6	21.35	27.42	4.72	1.57	1.80
Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6	21.32	5.88	2.21	1.10	0.74
oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5	21.28	19.44	4.22	1.47	1.83
pituitary gland - adult, donor10196.CNhs13805.10180-103C9	21.24	6.07	2.43	0.00	0.00
tongue, fetal, donor1.CNhs11768.10059-101H5	21.22	6.50	2.05	0.68	0.00
thalamus, adult, donor10252.CNhs12314.10154-103A1	21.20	15.83	1.65	0.41	0.31
Fibroblast - Periodontal Ligament, donor6 (PLH3).CNhs11996.11380-118B3	21.18	5.56	1.50	0.15	0.60
bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4	21.17	8.76	3.07	0.68	0.34
acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3	21.16	6.43	3.22	0.68	0.51
amniotic membrane cells, donor2.CNhs12503.12236-129G4	21.08	17.52	1.48	1.19	1.48
hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7	21.08	28.20	10.16	1.10	0.93
Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8	21.07	4.39	0.00	0.88	0.44
granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3	21.06	6.45	2.15	0.00	1.29
carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1	21.03	18.96	6.21	1.72	0.00
breast, adult, donor1.CNhs11792.10080-102A8	21.02	8.70	2.17	0.72	0.00
spinal cord - adult, donor10196.CNhs13807.10181-103D1	21.01	9.82	1.57	0.20	0.00
mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5	20.97	13.10	5.90	0.98	0.33
thyroid, adult, pool1.CNhs10634.10028-101E1	20.94	6.94	1.02	0.32	0.19
choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9	20.82	22.80	6.91	2.24	2.60
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2	20.81	12.38	4.21	0.26	0.53
mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7	20.80	7.51	1.35	0.00	0.19
colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9	20.78	7.63	2.83	0.57	0.85
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2	20.73	31.60	3.34	2.01	1.00
Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9	20.64	6.10	1.74	0.87	0.87
medulla oblongata - adult, donor10196.CNhs13800.10174-103C3	20.64	5.73	1.72	1.15	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3	20.59	7.46	1.78	0.00	0.71
bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8	20.57	10.16	2.13	1.65	1.65
hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4	20.54	3.60	1.44	0.00	0.36
acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9	20.53	20.96	9.10	1.06	1.06
acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9	20.50	8.99	4.77	0.00	0.84
Whole blood (ribopure), donor090325, donation1.CNhs11075.12176-128I7	20.49	46.46	3.81	0.71	1.67
Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3	20.38	3.48	0.99	0.00	0.00
giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1	20.31	13.69	5.47	1.01	0.58
retina, adult, pool1.CNhs10636.10030-101E3	20.30	12.01	1.79	0.36	0.50
locus coeruleus, adult, donor10252.CNhs12322.10165-103B3	20.23	14.28	2.12	0.53	0.40
CD14+ monocytes - treated with Cryptococcus, donor1.CNhs13472.11867-125B4	20.14	44.24	7.91	4.14	3.20
renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3	20.07	3.34	0.00	0.00	1.43
Olfactory epithelial cells, donor4.CNhs13819.11936-126A1	20.03	5.15	0.94	0.59	0.70
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6	20.01	2.31	1.54	0.77	0.00
Placental Epithelial Cells, donor1.CNhs11079.11278-116H9	20.01	8.79	0.61	0.61	0.30
skin, fetal, donor1.CNhs11774.10065-101I2	19.91	15.54	4.86	0.49	0.97
salivary acinar cells, donor1.CNhs12810.11771-123I7	19.89	13.47	2.69	1.45	1.86
testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6	19.77	28.06	8.28	1.34	0.27
acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9	19.74	8.38	1.89	0.54	0.54
CD4+CD25+CD45RA- memory regulatory T cells, donor2.CNhs13206.11797-124C6	19.72	37.66	5.76	2.88	3.32
rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1	19.62	14.85	3.92	0.84	0.28
Fibroblast - Gingival, donor1.CNhs10866.11237-116D4	19.60	4.90	0.82	0.41	0.20
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9	19.52	13.35	3.17	1.00	1.00
mesenchymal precursor cell - cardiac, donor2.CNhs12369.11753-123G7	19.51	2.27	1.06	0.30	0.60
medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3	19.50	9.00	1.75	0.87	1.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0).CNhs12908.12823-136I6	19.43	18.67	6.31	0.76	0.76
mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9	19.42	7.62	4.18	0.25	0.25
mesenchymal precursor cell - adipose, donor2.CNhs12364.11748-123G2	19.40	1.64	0.70	0.70	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6	19.40	10.40	2.60	1.40	0.80
Eosinophils, donor3.CNhs12549.12246-129H5	19.39	31.02	7.76	3.88	3.88
brain, adult, donor1.CNhs11796.10084-102B3	19.39	8.72	0.97	0.00	0.00
mesothelioma cell line:Mero-25.CNhs13066.10850-111F4	19.31	2.35	1.57	0.26	0.26
Lens Epithelial Cells, donor3.CNhs12572.11690-122I7	19.26	5.52	1.76	0.82	0.59
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6	19.18	9.34	3.53	0.25	0.50
acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9	19.17	10.27	3.20	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1	19.15	27.99	2.38	1.47	1.25
giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1	19.13	6.96	1.49	0.25	0.62
Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9	19.12	5.54	0.83	0.28	1.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h).CNhs13639.13311-142I8	18.98	14.76	4.22	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2.CNhs12475.13097-140D1	18.96	16.59	1.58	3.16	0.79
mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5	18.94	5.12	1.09	0.31	0.16
Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1	18.93	8.22	2.59	0.89	0.45
Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2	18.93	4.16	1.43	0.00	0.14
Trabecular Meshwork Cells, donor3.CNhs12124.11693-123A1	18.90	3.50	2.45	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3.CNhs12703.13163-141B4	18.89	15.45	4.29	0.00	2.58
CD8+ T Cells (pluriselect), donor090309, donation2.CNhs12178.12191-129B4	18.88	32.55	1.95	0.65	0.00
NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3	18.83	11.99	4.04	0.56	1.01
Gingival epithelial cells, donor2 (GEA14).CNhs11896.11302-117B6	18.82	9.27	0.27	3.27	0.00
frontal lobe, adult, pool1.CNhs10647.10040-101F4	18.80	8.93	1.27	0.63	0.70
Chondrocyte - de diff, donor1.CNhs11923.11261-116G1	18.79	1.81	0.00	0.72	1.08
Lens Epithelial Cells, donor1.CNhs12342.11529-119I8	18.76	1.44	4.33	0.00	0.00
nasal epithelial cells, donor1, tech_rep1.CNhs12589.12226-129F3	18.74	6.57	1.26	1.40	0.42
leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5	18.72	15.84	5.17	1.15	0.57
Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9	18.71	4.72	2.36	0.84	0.34
cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3	18.63	10.46	1.20	1.09	0.65
medial frontal gyrus - adult, donor10196.CNhs13796.10170-103B8	18.61	7.97	0.89	1.77	0.00
Osteoblast, donor2.CNhs11385.11354-117H4	18.60	4.65	0.66	0.00	0.00
choriocarcinoma cell line:SCH.CNhs11875.10785-110H2	18.58	15.86	4.78	0.87	0.98
optic nerve, donor1.CNhs13449.10277-104E7	18.56	9.99	1.43	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1	18.52	5.01	2.40	0.22	0.00
salivary gland, adult, pool1.CNhs11677.10093-102C3	18.50	9.03	0.43	1.72	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4	18.47	2.70	1.21	0.54	0.27
large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2	18.47	8.79	2.87	0.90	0.54
Eosinophils, donor2.CNhs12548.12245-129H4	18.45	38.22	3.95	11.86	7.91
chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1	18.45	11.97	2.83	0.83	1.50
neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9	18.44	4.45	1.59	0.32	0.32
Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9	18.42	4.91	0.46	1.38	0.31
hepatoma cell line:Li-7.CNhs11271.10484-107A7	18.41	7.78	1.77	0.49	0.10
esophagus, adult, pool1.CNhs10620.10015-101C6	18.33	13.87	1.36	1.16	0.78
chorionic membrane cells, donor2.CNhs12506.12239-129G7	18.32	8.52	0.82	0.73	0.64
uterus, fetal, donor1.CNhs11763.10055-101H1	18.31	8.54	2.03	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6	18.17	4.88	1.95	0.39	0.39
small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4	18.08	7.73	3.45	0.24	0.59
Preadipocyte - visceral, donor1.CNhs11082.11280-116I2	18.07	2.71	0.82	0.99	0.41
Small Airway Epithelial Cells, donor1.CNhs10884.11256-116F5	18.02	7.60	1.16	1.16	0.50
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0).CNhs12822.12627-134E8	18.01	20.10	9.06	0.93	0.93
mesenchymal precursor cell - ovarian cancer right ovary, donor2.CNhs12375.11759-123H4	18.00	4.91	0.36	0.18	0.55
synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9	17.99	16.72	2.52	0.00	0.63
brain, fetal, pool1.CNhs11797.10085-102B4	17.97	3.99	2.00	0.00	0.00
colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6	17.96	8.44	1.73	0.43	0.43
adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7	17.94	12.15	3.34	0.67	0.33
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02).CNhs12377.11761-123H6	17.94	3.54	0.97	0.54	0.32
Nucleus Pulposus Cell, donor3.CNhs12063.11462-119B4	17.90	4.07	1.90	0.27	0.81
Endothelial Cells - Artery, donor2.CNhs11977.11341-117F9	17.88	8.80	3.30	0.55	1.10
mesenchymal precursor cell - cardiac, donor1.CNhs12368.11752-123G6	17.85	2.52	0.69	0.23	0.23
Fibroblast - Dermal, donor5.CNhs12055.11454-119A5	17.81	7.12	3.08	1.13	0.16
Pancreatic stromal cells, donor1.CNhs10877.11249-116E7	17.81	5.73	0.43	0.78	0.52
heart, adult, diseased post-infarction, donor1.CNhs11757.10050-101G5	17.77	11.18	2.40	1.60	1.00
Melanocyte, donor2 (MC+2).CNhs13156.12739-135I3	17.72	6.91	1.20	2.40	0.30
nucleus accumbens, adult, pool1.CNhs10644.10037-101F1	17.60	8.80	1.54	0.96	0.51
Fibroblast - skin spinal muscular atrophy, donor1.CNhs11074.11555-120C7	17.58	6.81	0.92	0.28	0.46
medulla oblongata, adult, pool1.CNhs10645.10038-101F2	17.57	9.94	1.49	0.31	0.25
mesenchymal precursor cell - ovarian cancer metastasis, donor1.CNhs12374.11758-123H3	17.55	2.39	0.27	0.53	0.53
brain, adult, pool1.CNhs10617.10012-101C3	17.53	6.40	1.02	0.19	0.09
gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3	17.50	10.81	4.29	0.51	0.51
Amniotic Epithelial Cells, donor1.CNhs11341.11533-120A3	17.48	12.01	2.18	0.44	0.44
Fibroblast - skin normal, donor2.CNhs11914.11561-120D4	17.44	3.80	1.07	0.00	0.49
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8	17.42	30.10	3.07	2.05	0.90
acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6	17.40	9.80	5.15	1.23	0.74
corpus callosum, adult, pool1.CNhs10649.10042-101F6	17.39	12.74	2.09	0.34	0.27
parietal lobe, adult, pool1.CNhs10641.10034-101E7	17.38	10.02	1.40	0.76	0.32
Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6	17.32	8.03	2.26	1.00	0.50
Fibroblast - Gingival, donor5 (GFH3).CNhs11952.11303-117B7	17.31	6.68	1.24	1.24	0.49
Whole blood (ribopure), donor090325, donation2.CNhs11076.12177-128I8	17.28	44.43	4.11	2.47	3.29
Keratocytes, donor1.CNhs11337.11527-119I6	17.27	1.63	0.00	0.00	0.00
liver, fetal, pool1.CNhs11798.10086-102B5	17.23	3.98	5.30	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4	17.22	16.55	3.36	0.67	0.89
Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6	17.20	3.69	0.96	0.14	0.68
mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9	17.17	4.63	1.35	0.19	0.58
Whole blood (ribopure), donor090309, donation3.CNhs11948.12181-129A3	17.09	42.72	3.42	1.71	2.28
Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9	17.07	10.64	1.55	1.55	0.44
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3	17.05	26.18	3.45	1.45	0.56
Smooth Muscle Cells - Tracheal, donor3.CNhs12894.11674-122G9	17.05	5.90	3.28	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3.CNhs11912.11559-120D2	17.03	5.24	0.71	0.40	0.30
Endothelial Cells - Thoracic, donor2.CNhs11978.11343-117G2	17.01	6.48	1.62	1.62	0.81
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1.CNhs11084.11282-116I4	17.01	6.86	2.05	0.36	0.45
embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9	17.00	5.39	2.18	0.31	1.14
xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5	16.99	9.30	2.56	1.28	0.64
normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3	16.93	5.64	2.12	0.71	1.76
tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5	16.89	5.30	1.89	0.27	0.27
Fibroblast - Dermal, donor6.CNhs12059.11458-119A9	16.85	5.76	2.11	0.56	0.42
non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1	16.81	8.01	0.80	0.00	0.80
Endothelial Cells - Lymphatic, donor1.CNhs10865.11236-116D3	16.80	8.79	1.81	1.03	0.26
Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8	16.80	3.43	0.71	0.95	0.59
Whole blood (ribopure), donor090309, donation1.CNhs11675.12179-129A1	16.75	38.06	1.01	0.51	1.52
Hair Follicle Dermal Papilla Cells, donor2.CNhs11979.11348-117G7	16.72	7.08	0.00	0.64	0.00
Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5	16.67	5.56	1.01	0.51	1.35
Endothelial Cells - Aortic, donor2.CNhs11375.11340-117F8	16.66	3.47	2.43	1.04	0.35
Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9	16.65	3.97	1.99	0.88	0.44
Fibroblast - Conjunctival, donor1.CNhs11339.11531-120A1	16.64	4.22	0.94	0.23	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2.CNhs12104.11627-122B7	16.64	3.12	0.00	0.00	0.00
Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2	16.62	4.94	1.36	0.60	0.60
mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1	16.61	4.59	1.06	0.88	0.88
gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2	16.58	10.39	2.20	1.60	0.20
melanoma cell line:G-361.CNhs11254.10465-106H6	16.56	2.57	0.57	0.00	0.00
maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9	16.49	6.75	1.26	0.31	0.31
medial temporal gyrus - adult, donor10196.CNhs13809.10183-103D3	16.47	8.30	1.34	0.73	0.73
umbilical cord, fetal, donor1.CNhs11765.10057-101H3	16.42	4.69	2.35	2.35	0.00
Prostate Stromal Cells, donor2.CNhs11973.11332-117E9	16.39	2.91	1.46	0.91	0.73
tenocyte, donor1.CNhs12639.11763-123H8	16.37	4.46	0.37	0.74	0.00
Tracheal Epithelial Cells, donor1.CNhs11092.11292-117A5	16.36	4.33	0.96	0.77	0.48
Mesenchymal stem cells - hepatic, donor0.CNhs10845.11218-116B3	16.35	4.26	0.00	0.71	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5	16.35	8.27	3.03	1.01	1.01
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9	16.30	24.04	3.04	1.11	1.93
paracentral gyrus, adult, pool1.CNhs10642.10035-101E8	16.28	8.31	1.89	0.54	0.41
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G).CNhs13507.11842-124H6	16.24	6.50	1.39	0.46	0.00
globus pallidus - adult, donor10196.CNhs13801.10175-103C4	16.21	4.20	4.20	0.60	0.60
Prostate Stromal Cells, donor3.CNhs12015.11405-118E1	16.13	4.06	0.52	0.66	0.66
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5	16.09	3.34	1.77	0.78	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2.CNhs12105.11629-122B9	16.08	9.19	1.15	0.00	0.00
CD14+CD16- Monocytes, donor3.CNhs13540.11910-125G2	16.07	27.64	3.70	1.13	1.45
Sertoli Cells, donor1.CNhs10851.11255-116F4	16.07	1.61	0.00	1.61	0.00
Gingival epithelial cells, donor3 (GEA15).CNhs11903.11379-118B2	16.06	5.74	0.86	0.57	0.86
Meningeal Cells, donor3.CNhs12731.11654-122E7	16.06	7.19	1.17	0.66	0.73
insula, adult, pool1.CNhs10646.10039-101F3	16.04	8.44	1.46	0.49	0.24
Fibroblast - skin dystrophia myotonica, donor1.CNhs11353.11556-120C8	16.02	4.70	1.07	0.43	0.00
Melanocyte - dark, donor3.CNhs12570.11663-122F7	16.00	5.02	0.95	0.57	0.25
mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1	15.97	2.54	0.60	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5	15.95	27.63	2.96	0.99	0.99
Osteoblast - differentiated, donor2.CNhs11980.11353-117H3	15.92	4.55	4.55	0.00	0.00
amygdala - adult, donor10196.CNhs13793.10167-103B5	15.91	10.94	2.98	1.99	0.00
Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4	15.90	6.68	2.20	0.35	0.53
Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3	15.87	7.16	2.18	0.00	0.31
Fibroblast - skin spinal muscular atrophy, donor2.CNhs11911.11558-120D1	15.84	3.07	0.81	0.81	0.48
eye, fetal, donor1.CNhs11762.10054-101G9	15.82	9.49	1.58	0.45	0.23
Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1	15.67	4.34	2.41	0.96	0.00
Osteoblast, donor3.CNhs12036.11426-118G4	15.67	4.61	0.18	0.92	0.18
acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1	15.67	9.56	5.01	1.41	0.78
amniotic membrane cells, donor3.CNhs12379.12237-129G5	15.67	17.82	1.54	1.54	1.23
Melanocyte - light, donor1.CNhs11303.11274-116H5	15.66	2.67	0.76	1.53	0.38
mesothelioma cell line:Mero-41.CNhs13067.10851-111F5	15.64	2.04	1.13	0.68	0.45
spinal cord, fetal, donor1.CNhs11764.10056-101H2	15.64	12.26	2.11	1.69	0.42
Preadipocyte - visceral, donor2.CNhs11982.11357-117H7	15.58	3.63	0.52	0.00	0.00
mesenchymal precursor cell - adipose, donor3.CNhs12365.11749-123G3	15.53	2.22	0.00	1.11	0.00
Osteoblast - differentiated, donor3.CNhs12035.11425-118G3	15.52	3.10	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2	15.46	8.59	2.58	0.29	0.86
pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4	15.43	5.66	0.86	0.34	0.34
testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3	15.40	21.72	10.30	2.96	1.73
Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2	15.37	9.64	0.98	0.16	0.65
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5	15.29	7.64	0.96	0.00	0.00
neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9	15.28	12.39	4.75	1.02	0.34
Smooth Muscle Cells - Prostate, donor2.CNhs11976.11335-117F3	15.27	4.52	0.42	0.14	0.00
Fibroblast - skin dystrophia myotonica, donor2.CNhs11354.11557-120C9	15.26	3.39	0.42	0.64	0.00
Keratinocyte - epidermal, donor1.CNhs11064.11272-116H3	15.26	8.34	2.30	1.54	0.99
acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5	15.26	8.12	3.57	0.00	0.97
tenocyte, donor2.CNhs12640.11765-123I1	15.25	4.62	1.85	0.46	0.92
Anulus Pulposus Cell, donor2.CNhs12064.11463-119B5	15.24	4.31	2.32	0.00	0.00
mature adipocyte, donor1.CNhs12558.12231-129F8	15.23	7.62	0.00	0.00	0.00
Myoblast, donor3.CNhs11908.11398-118D3	15.22	3.94	1.61	0.54	0.36
hippocampus - adult, donor10196.CNhs13795.10169-103B7	15.11	7.16	3.18	1.59	0.80
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2.CNhs13420.13230-141I8	15.11	6.18	1.37	0.00	0.00
Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6	15.10	7.41	1.37	0.27	0.27
Nucleus Pulposus Cell, donor1.CNhs10881.11252-116F1	15.09	3.68	1.72	0.25	0.12
mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2	15.05	2.44	0.81	0.41	0.41
thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9	15.03	6.73	3.03	0.78	0.11
clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6	15.02	6.04	0.65	0.33	0.49
Fibroblast - Gingival, donor2.CNhs11961.11318-117D4	14.99	6.26	1.47	0.37	0.61
Neutrophils, donor2.CNhs11959.11314-117C9	14.96	68.81	0.00	0.00	8.97
epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2	14.96	4.30	1.72	0.52	0.17
Sebocyte, donor2.CNhs11951.11301-117B5	14.95	2.60	0.65	0.00	0.65
Fibroblast - Aortic Adventitial, donor1.CNhs10874.11245-116E3	14.94	4.43	1.52	0.25	0.51
Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1	14.89	4.69	2.07	0.96	0.41
biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7	14.84	7.16	2.56	1.02	1.02
mesenchymal precursor cell - bone marrow, donor2.CNhs12367.11751-123G5	14.84	5.79	0.00	0.25	0.50
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3	14.83	8.47	0.79	1.32	0.93
Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7	14.82	5.37	1.72	0.32	0.64
occipital lobe, adult, donor1.CNhs11787.10076-102A4	14.77	12.72	1.85	0.21	0.62
mature adipocyte, donor4.CNhs12562.12234-129G2	14.75	5.25	0.66	0.00	0.66
glioma cell line:GI-1.CNhs10731.10413-106B8	14.74	6.93	2.02	0.29	0.58
Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1	14.73	4.71	1.06	0.59	0.47
myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9	14.73	4.60	2.58	0.37	0.55
mature adipocyte, donor3.CNhs12560.12233-129G1	14.70	4.29	0.61	0.92	0.31
Fibroblast - Cardiac, donor5.CNhs12057.11456-119A7	14.68	8.62	1.21	0.54	0.27
mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9	14.64	3.25	1.03	0.30	0.59
Keratinocyte - oral, donor1.CNhs10879.11251-116E9	14.63	5.74	2.04	0.74	0.56
migratory langerhans cells, donor2.CNhs13536.11902-125F3	14.62	19.27	2.66	0.80	0.40
mesenchymal precursor cell - cardiac, donor3.CNhs12370.11754-123G8	14.61	3.73	0.31	0.31	0.31
peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4	14.60	10.02	5.10	0.53	0.18
Endothelial Cells - Lymphatic, donor2.CNhs11901.11317-117D3	14.59	7.47	1.42	0.71	0.71
meningioma cell line:HKBMM.CNhs11945.10691-109F7	14.59	7.29	2.12	0.71	0.47
postcentral gyrus, adult, pool1.CNhs10638.10032-101E5	14.54	8.29	0.86	0.39	0.20
diencephalon, adult.CNhs12610.10193-103E4	14.52	8.20	1.64	1.17	0.23
mesothelioma cell line:Mero-84.CNhs13072.10855-111F9	14.51	4.63	1.54	0.93	0.31
Lens Epithelial Cells, donor2.CNhs12568.11609-120I7	14.49	7.77	2.55	0.23	0.46
Mesenchymal Stem Cells - Wharton's Jelly, donor1.CNhs11057.11548-120B9	14.48	3.62	0.52	0.78	0.26
chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4	14.42	7.78	1.90	0.57	1.33
mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1	14.40	4.00	0.80	0.00	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2.CNhs11988.11364-117I5	14.38	6.58	1.46	1.22	0.73
somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7	14.38	16.03	0.71	0.94	1.65
Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7	14.36	5.95	1.74	0.73	0.00
Olfactory epithelial cells, donor3.CNhs13818.11935-125I9	14.35	4.10	0.16	0.16	0.32
Preadipocyte - omental, donor2.CNhs11902.11329-117E6	14.33	2.56	0.51	0.00	0.00
Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2	14.33	6.93	1.39	0.15	0.92
Gingival epithelial cells, donor1 (GEA11).CNhs11061.11221-116B6	14.30	10.82	1.55	0.39	1.35
Preadipocyte - visceral, donor3.CNhs12039.11429-118G7	14.29	3.02	0.35	0.70	0.12
chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9	14.29	10.20	4.08	0.47	0.78
mature adipocyte, donor2.CNhs12559.12232-129F9	14.29	6.02	1.25	0.75	1.00
Whole blood (ribopure), donor090612, donation3.CNhs11949.12184-129A6	14.28	54.73	4.76	0.79	3.97
tenocyte, donor3.CNhs12641.11768-123I4	14.28	4.76	0.87	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2	14.24	4.75	1.66	0.71	0.95
mesothelioma cell line:Mero-83.CNhs13070.10854-111F8	14.15	9.13	2.87	0.72	1.25
neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4	14.15	4.09	1.10	0.47	0.16
Meningeal Cells, donor1.CNhs11320.11493-119E8	14.13	4.82	1.01	0.34	0.11
thalamus - adult, donor10196.CNhs13794.10168-103B6	14.10	8.29	1.66	0.83	0.83
mesenchymal precursor cell - ovarian cancer metastasis, donor2.CNhs13093.11835-124G8	14.09	6.26	3.65	0.00	0.00
Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8	14.07	6.94	2.41	0.70	0.90
temporal lobe, adult, pool1.CNhs10637.10031-101E4	14.07	6.53	1.36	0.34	0.20
Mallassez-derived cells, donor1 (MZH3).CNhs12538.12142-128E9	14.06	4.69	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h).CNhs13650.13323-143B2	14.06	9.04	1.51	1.00	0.00
Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6	14.03	2.78	0.77	0.46	0.46
Adipocyte - perirenal, donor1.CNhs12069.11476-119C9	13.96	1.74	0.87	1.74	0.87
mesenchymal precursor cell - ovarian cancer left ovary, donor2.CNhs13092.11833-124G6	13.94	9.90	0.90	0.45	0.00
alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6	13.92	7.67	2.84	0.28	0.28
Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6	13.82	5.22	3.22	0.46	0.77
Endothelial Cells - Vein, donor1.CNhs12497.11267-116G7	13.80	4.60	1.53	0.00	1.53
Bronchial Epithelial Cell, donor4.CNhs12054.11453-119A4	13.79	3.68	1.84	0.92	0.00
Macrophage - monocyte derived, donor1.CNhs10861.11232-116C8	13.79	22.41	2.46	0.98	0.74
Sebocyte, donor1.CNhs10847.11220-116B5	13.78	4.02	1.72	1.72	0.00
Olfactory epithelial cells, donor1.CNhs13816.11933-125I7	13.73	5.20	1.46	0.62	0.42
occipital pole, adult, pool1.CNhs10643.10036-101E9	13.69	6.43	0.69	0.21	0.48
CD14+CD16- Monocytes, donor2.CNhs13216.11799-124C8	13.67	29.28	3.60	1.35	1.80
CD14+CD16- Monocytes, donor1.CNhs13224.11788-124B6	13.59	32.46	4.49	3.03	1.68
left atrium, adult, donor1.CNhs11790.10079-102A7	13.58	6.43	2.14	0.71	0.00
migratory langerhans cells, donor3.CNhs13547.11903-125F4	13.58	13.09	2.62	0.49	0.16
Mesenchymal Stem Cells - amniotic membrane, donor1.CNhs11349.11547-120B8	13.56	6.12	1.33	0.27	0.27
Smooth Muscle Cells - Aortic, donor1.CNhs11085.11283-116I5	13.55	3.08	2.16	0.62	0.31
Synoviocyte, donor3.CNhs12050.11440-118H9	13.50	4.94	0.66	0.99	0.33
Melanocyte, donor3 (MC+3).CNhs13406.12837-137B2	13.43	6.86	3.43	1.71	0.86
Endothelial Cells - Lymphatic, donor3.CNhs11906.11393-118C7	13.39	11.38	2.68	1.67	0.00
Melanocyte, donor1 (MC+1).CNhs12816.12641-134G4	13.37	9.25	2.47	0.31	1.23
Myoblast, donor2.CNhs11965.11322-117D8	13.36	8.22	0.62	0.62	0.21
caudate nucleus - adult, donor10196.CNhs13802.10177-103C6	13.29	6.20	1.77	0.00	0.00
Mallassez-derived cells, donor2.CNhs13550.11929-125I3	13.27	7.56	1.68	0.84	0.84
mesenchymal precursor cell - bone marrow, donor1.CNhs12366.11750-123G4	13.26	3.41	0.76	0.19	0.38
Olfactory epithelial cells, donor2.CNhs13817.11934-125I8	13.20	3.39	0.71	0.36	0.36
Mesenchymal Stem Cells - umbilical, donor3.CNhs12127.11700-123A8	13.17	2.47	1.65	0.00	0.00
lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8	13.17	3.59	0.00	0.00	0.00
Preadipocyte - breast, donor1.CNhs11052.11467-119B9	13.15	2.98	0.99	0.74	0.00
liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8	13.12	5.11	0.51	0.68	0.17
Macrophage - monocyte derived, donor2.CNhs11899.11313-117C8	13.10	8.66	0.47	1.40	0.47
Mammary Epithelial Cell, donor3.CNhs12032.11422-118F9	13.04	4.22	0.38	0.77	0.38
Preadipocyte - omental, donor3.CNhs12013.11403-118D8	13.03	3.06	0.48	0.80	0.16
Retinal Pigment Epithelial Cells, donor3.CNhs12733.11689-122I6	13.02	4.88	2.28	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1	12.97	6.33	0.63	0.32	0.32
Whole blood (ribopure), donor090612, donation1.CNhs11672.12182-129A4	12.97	38.91	3.24	0.65	1.95
Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9	12.95	8.89	2.36	0.47	0.66
Fibroblast - Cardiac, donor1.CNhs12498.11268-116G8	12.90	1.68	2.24	1.12	1.12
Prostate Stromal Cells, donor1.CNhs10883.11254-116F3	12.86	3.79	0.46	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3).CNhs13738.13366-143F9	12.77	16.79	5.47	1.82	0.00
Mesenchymal Stem Cells - bone marrow, donor2.CNhs12100.11616-122A5	12.77	1.42	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3	12.77	4.48	0.82	0.41	0.41
glioblastoma cell line:T98G.CNhs11272.10485-107A8	12.75	2.65	1.02	0.10	0.41
Mesenchymal Stem Cells - hepatic, donor2.CNhs12730.11618-122A7	12.73	5.00	1.29	0.29	0.14
Placental Epithelial Cells, donor3.CNhs12037.11427-118G5	12.70	4.23	1.51	0.00	0.30
anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3	12.69	16.48	6.43	1.48	1.48
Fibroblast - Choroid Plexus, donor2.CNhs12344.11572-120E6	12.68	6.34	1.73	1.15	0.00
Preadipocyte - subcutaneous, donor3.CNhs12038.11428-118G6	12.61	1.78	0.36	0.18	0.18
left ventricle, adult, donor1.CNhs11789.10078-102A6	12.58	7.95	1.32	0.00	0.66
Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9	12.57	5.39	2.31	0.77	0.77
Renal Epithelial Cells, donor1.CNhs11332.11517-119H5	12.55	4.71	0.78	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4	12.53	15.42	3.69	1.93	1.61
heart, adult, diseased, donor1.CNhs11758.10051-101G6	12.45	6.87	1.29	0.86	0.00
pons, adult, pool1.CNhs10640.10033-101E6	12.44	9.24	1.02	0.20	0.54
keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8	12.41	7.38	2.68	0.00	1.01
CD14-CD16+ Monocytes, donor2.CNhs13207.11800-124C9	12.33	33.62	2.98	2.39	1.99
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3	12.28	11.65	2.52	0.94	0.63
Fibroblast - Periodontal Ligament, donor5 (PL30).CNhs11953.11304-117B8	12.26	2.45	0.00	0.00	0.00
lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7	12.25	18.58	7.90	1.58	0.79
Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6	12.23	6.12	0.36	1.26	0.36
Smooth Muscle Cells - Aortic, donor3.CNhs11309.11432-118H1	12.18	3.48	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6	12.16	9.02	2.55	0.78	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3.CNhs13421.13231-141I9	12.12	3.03	0.67	0.67	0.00
Cardiac Myocyte, donor2.CNhs12350.11605-120I3	12.07	7.38	0.67	0.00	1.34
Mesenchymal Stem Cells - bone marrow, donor3.CNhs12126.11697-123A5	11.99	2.40	0.53	0.27	0.27
Tracheal Epithelial Cells, donor3.CNhs12051.11441-118I1	11.98	4.36	1.09	0.00	2.18
oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2	11.97	16.88	3.83	1.37	0.98
Fibroblast - Pulmonary Artery, donor1.CNhs10878.11250-116E8	11.91	4.20	1.36	0.23	0.23
Whole blood (ribopure), donor090612, donation2.CNhs11673.12183-129A5	11.88	35.64	3.78	0.00	1.62
fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2	11.79	6.30	4.25	0.41	0.55
Mallassez-derived cells, donor3.CNhs13551.11930-125I4	11.77	5.25	0.57	0.99	0.43
Trabecular Meshwork Cells, donor1.CNhs11340.11532-120A2	11.76	2.66	1.52	0.00	0.00
mesothelioma cell line:No36.CNhs13074.10857-111G2	11.74	4.49	1.04	1.38	1.04
Fibroblast - skin normal, donor1.CNhs11351.11553-120C5	11.73	3.72	0.37	0.56	0.37
Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2	11.73	5.21	1.95	0.65	0.98
Endothelial Cells - Microvascular, donor1.CNhs11925.11265-116G5	11.68	3.63	1.21	0.40	0.40
Preadipocyte - omental, donor1.CNhs11065.11468-119C1	11.66	4.87	0.51	0.13	0.64
Fibroblast - Choroid Plexus, donor1.CNhs11319.11492-119E7	11.65	6.05	1.06	0.15	0.30
Placental Epithelial Cells, donor2.CNhs11386.11355-117H5	11.65	6.66	0.00	0.00	0.00
Prostate Epithelial Cells, donor2.CNhs11972.11331-117E8	11.63	11.03	1.20	3.21	1.40
papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5	11.63	4.59	2.62	0.33	0.16
mesenchymal precursor cell - ovarian cancer left ovary, donor4.CNhs13094.11836-124G9	11.61	2.07	0.83	0.00	0.00
skeletal muscle, fetal, donor1.CNhs11776.10066-101I3	11.60	6.96	3.48	0.00	1.16
Renal Glomerular Endothelial Cells, donor2.CNhs12086.11594-120H1	11.57	3.40	1.02	1.36	0.34
mesenchymal precursor cell - bone marrow, donor3.CNhs13098.11840-124H4	11.57	0.89	0.00	0.00	0.00
Adipocyte - breast, donor2.CNhs11969.11327-117E4	11.56	6.42	1.07	1.07	0.21
fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9	11.53	5.56	1.79	0.20	0.60
acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8	11.38	17.96	3.59	0.40	0.20
Fibroblast - skin walker warburg, donor1.CNhs11352.11554-120C6	11.36	4.07	0.34	0.51	0.34
mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8	11.27	9.99	1.54	0.26	0.77
Adipocyte - subcutaneous, donor3.CNhs12017.11408-118E4	11.23	2.87	0.78	0.78	0.26
Neutrophils, donor3.CNhs11905.11390-118C4	11.19	55.53	1.24	4.14	3.73
Chondrocyte - de diff, donor3.CNhs12020.11410-118E6	11.15	4.49	0.58	0.58	0.14
CD14-CD16+ Monocytes, donor1.CNhs13229.11790-124B8	11.12	31.07	4.85	2.57	2.57
Hepatic Stellate Cells (lipocyte), donor1.CNhs11335.11524-119I3	11.11	3.70	0.41	0.00	0.41
Myoblast, donor1.CNhs10870.11241-116D8	11.00	4.49	0.43	0.72	0.29
Nucleus Pulposus Cell, donor2.CNhs12019.11409-118E5	11.00	7.50	1.00	0.00	1.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h).CNhs13646.13317-143A5	10.95	4.86	1.22	0.00	0.00
Preadipocyte - breast, donor2.CNhs11971.11328-117E5	10.95	6.46	1.96	0.28	0.28
Smooth Muscle Cells - Umbilical Vein, donor2.CNhs12569.11621-122B1	10.91	3.64	1.38	0.29	0.29
Esophageal Epithelial Cells, donor1.CNhs11323.11507-119G4	10.90	3.49	0.87	0.44	0.44
small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6	10.82	4.70	0.94	0.47	1.41
Endothelial Cells - Vein, donor3.CNhs12026.11416-118F3	10.81	6.60	2.93	0.92	0.92
myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7	10.78	10.35	1.92	0.11	0.21
CD14+CD16+ Monocytes, donor1.CNhs13541.11789-124B7	10.77	22.18	4.86	1.69	1.69
Adipocyte - omental, donor1.CNhs11054.11473-119C6	10.71	5.07	0.99	0.56	0.14
Fibroblast - Cardiac, donor2.CNhs11378.11345-117G4	10.67	1.07	3.20	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1).CNhs13157.12382-131E6	10.65	6.02	1.85	0.00	0.00
Synoviocyte, donor2.CNhs11992.11368-117I9	10.56	5.07	0.21	0.63	0.21
mesothelioma cell line:Mero-95.CNhs13073.10856-111G1	10.53	7.02	3.07	0.22	0.66
Retinal Pigment Epithelial Cells, donor1.CNhs11338.11528-119I7	10.50	4.92	1.97	0.00	0.33
Endothelial Cells - Microvascular, donor3.CNhs12024.11414-118F1	10.49	7.32	2.93	0.49	0.24
Cardiac Myocyte, donor3.CNhs12571.11686-122I3	10.48	4.86	0.51	0.13	0.38
Meningeal Cells, donor2.CNhs12080.11573-120E7	10.46	4.80	3.05	0.44	0.00
CD14+CD16+ Monocytes, donor2.CNhs13208.11801-124D1	10.42	24.66	3.19	4.25	1.91
gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1	10.42	6.65	1.20	0.56	0.56
Astrocyte - cerebellum, donor2.CNhs12081.11580-120F5	10.40	6.12	0.82	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor3.CNhs12378.11762-123H7	10.37	5.71	0.60	0.75	0.60
migratory langerhans cells, donor1.CNhs13535.11901-125F2	10.33	10.72	1.75	0.78	0.39
Mesenchymal stem cells - umbilical, donor0.CNhs12492.11214-116A8	10.30	4.75	0.79	0.79	0.00
Hepatic Stellate Cells (lipocyte), donor2.CNhs12093.11604-120I2	10.29	0.00	7.35	0.00	0.00
Pericytes, donor2.CNhs12079.11571-120E5	10.29	3.43	0.69	0.00	0.69
basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9	10.26	3.11	0.62	0.62	0.93
Endothelial Cells - Artery, donor3.CNhs12023.11413-118E9	10.24	3.34	2.09	0.00	0.21
glioblastoma cell line:A172.CNhs11185.10444-106F3	10.15	5.02	0.52	0.21	0.31
renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6	10.15	4.53	0.43	0.86	0.65
Urothelial Cells, donor2.CNhs12091.11600-120H7	10.11	0.00	5.05	1.68	0.00
Tracheal Epithelial Cells, donor2.CNhs11993.11369-118A1	10.05	5.36	0.67	0.67	2.01
Astrocyte - cerebellum, donor3.CNhs12117.11661-122F5	10.03	5.02	1.25	0.31	0.31
CD8+ T Cells (pluriselect), donor090612, donation1.CNhs12182.12201-129C5	9.99	29.98	2.50	3.75	0.00
Renal Proximal Tubular Epithelial Cell, donor2.CNhs12087.11595-120H2	9.97	6.65	0.83	0.83	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5	9.96	9.96	6.87	0.00	0.34
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7	9.93	4.34	3.10	0.00	0.00
clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8	9.92	6.12	0.84	0.21	0.00
Corneal Epithelial Cells, donor1.CNhs11336.11526-119I5	9.84	2.55	0.73	0.00	0.00
Adipocyte - omental, donor3.CNhs12068.11475-119C8	9.83	1.79	0.89	0.00	0.89
cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5	9.80	3.65	1.94	0.11	0.34
Pericytes, donor1.CNhs11317.11491-119E6	9.79	3.92	0.59	0.00	0.00
Chondrocyte - re diff, donor3.CNhs12021.11411-118E7	9.73	7.30	1.95	0.00	0.97
mesothelioma cell line:ONE58.CNhs13075.10858-111G3	9.72	2.43	0.30	0.00	0.30
Fibroblast - Dermal, donor3.CNhs12028.11418-118F5	9.71	2.54	0.45	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ).CNhs13276.12504-133A2	9.70	8.94	1.52	1.14	0.38
Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3	9.69	5.61	1.02	0.51	0.00
Smooth Muscle Cells - Coronary Artery, donor3.CNhs12045.11435-118H4	9.69	4.21	0.42	0.00	0.00
Macrophage - monocyte derived, donor3.CNhs12003.11389-118C3	9.66	15.90	1.49	2.08	1.63
Fibroblast - Cardiac, donor3.CNhs12027.11417-118F4	9.62	7.40	0.49	0.49	0.99
Hepatic Sinusoidal Endothelial Cells, donor1.CNhs12075.11521-119H9	9.60	8.12	2.21	0.00	0.00
teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6	9.59	13.12	5.17	0.63	1.39
Smooth Muscle Cells - Carotid, donor1.CNhs11087.11285-116I7	9.55	1.91	0.32	0.32	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4.CNhs13096.11837-124H1	9.55	8.36	0.80	0.00	0.40
Anulus Pulposus Cell, donor1.CNhs10876.11248-116E6	9.53	4.70	1.24	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2	9.30	5.11	2.32	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7	9.23	10.40	4.20	1.34	0.17
Mesothelial Cells, donor3.CNhs12012.11402-118D7	9.20	8.20	1.70	0.60	0.60
normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2	9.19	5.51	0.61	0.31	0.61
Smooth Muscle Cells - Brain Vascular, donor3.CNhs12004.11391-118C5	9.15	7.05	0.57	0.95	1.53
Bronchial Epithelial Cell, donor5.CNhs12058.11457-119A8	9.04	7.23	1.51	1.51	0.60
Endothelial Cells - Aortic, donor3.CNhs12022.11412-118E8	9.04	9.04	0.57	1.70	1.13
Adipocyte - omental, donor2.CNhs12067.11474-119C7	9.01	4.00	1.00	3.00	0.00
Neutrophils, donor1.CNhs10862.11233-116C9	8.99	77.15	2.25	9.74	3.75
Smooth Muscle Cells - Umbilical Artery, donor2.CNhs11991.11367-117I8	8.98	6.20	1.55	0.00	0.31
Smooth Muscle Cells - Brain Vascular, donor1.CNhs10863.11234-116D1	8.93	7.44	0.37	0.37	1.12
Corneal Epithelial Cells, donor3.CNhs12123.11687-122I4	8.90	4.08	1.48	0.00	0.00
Bronchial Epithelial Cell, donor6.CNhs12062.11461-119B3	8.87	5.18	0.74	0.00	1.48
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1.CNhs11350.11549-120C1	8.87	6.71	1.44	0.00	0.24
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32).CNhs13369.12750-136A5	8.78	7.32	1.95	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1.CNhs11324.11508-119G5	8.78	0.98	0.49	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1.CNhs11344.11536-120A6	8.75	3.34	0.51	1.03	0.26
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1).CNhs13339.12642-134G5	8.74	5.38	0.67	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1.CNhs11347.11539-120A9	8.68	4.88	0.00	0.54	0.00
Smooth Muscle Cells - Subclavian Artery, donor2.CNhs11990.11366-117I7	8.62	3.98	1.33	0.66	0.66
Endothelial Cells - Aortic, donor0.CNhs10837.11207-116A1	8.55	3.98	0.80	0.40	0.40
Melanocyte - light, donor3.CNhs12033.11423-118G1	8.55	1.71	1.71	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1.CNhs13826.13433-144E4	8.53	18.98	6.46	0.41	0.96
Smooth Muscle Cells - Uterine, donor3.CNhs11927.11466-119B8	8.51	1.42	0.00	0.35	0.00
endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4	8.50	8.68	1.74	1.21	1.04
Urothelial Cells, donor3.CNhs12122.11681-122H7	8.43	3.10	2.22	1.77	0.44
Hepatic Sinusoidal Endothelial Cells, donor2.CNhs12092.11601-120H8	8.41	2.80	1.40	1.40	1.40
Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3	8.39	10.09	2.62	0.77	0.46
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1).CNhs11936.12260-130A1	8.37	7.22	1.44	0.58	0.58
Renal Epithelial Cells, donor3.CNhs12732.11678-122H4	8.34	10.45	2.22	0.63	0.32
Keratocytes, donor2.CNhs12095.11607-120I5	8.32	1.04	0.00	1.04	0.00
Fibroblast - Lymphatic, donor1.CNhs11322.11506-119G3	8.19	2.73	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3.CNhs12125.11694-123A2	8.18	6.86	2.64	0.26	0.79
Urothelial Cells, donor1.CNhs11334.11520-119H8	8.18	6.46	0.86	1.72	0.86
Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6	8.13	6.28	1.23	0.25	0.12
Osteoblast - differentiated, donor1.CNhs11311.11276-116H7	8.13	4.51	0.90	0.00	0.30
Alveolar Epithelial Cells, donor1.CNhs11325.11510-119G7	8.11	2.95	0.49	0.98	0.49
Endothelial Cells - Artery, donor1.CNhs12496.11264-116G4	7.97	4.61	1.68	0.84	0.42
Smooth Muscle Cells - Brachiocephalic, donor1.CNhs11086.11284-116I6	7.97	4.82	1.11	0.56	0.56
Renal Glomerular Endothelial Cells, donor1.CNhs12074.11514-119H2	7.96	1.14	2.27	0.00	0.00
Fibroblast - Lymphatic, donor3.CNhs12118.11667-122G2	7.90	1.44	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5	7.90	7.22	2.93	0.68	0.90
Hair Follicle Outer Root Sheath Cells, donor1.CNhs12339.11504-119G1	7.89	6.04	0.46	0.00	0.00
Iris Pigment Epithelial Cells, donor1.CNhs12596.11530-119I9	7.89	6.00	1.72	0.86	0.34
Smooth Muscle Cells - Umbilical Artery, donor3.CNhs12049.11439-118H8	7.89	2.82	0.28	0.00	0.00
Keratinocyte - epidermal, donor2.CNhs11381.11349-117G8	7.87	3.37	0.00	0.00	1.12
teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7	7.87	17.59	6.67	0.87	0.87
CD14-CD16+ Monocytes, donor3.CNhs13548.11911-125G3	7.85	26.85	3.65	2.19	1.46
Smooth Muscle Cells - Umbilical artery, donor0.CNhs10839.11212-116A6	7.85	3.57	0.36	0.00	0.36
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2).CNhs13358.12740-135I4	7.84	2.41	0.00	0.60	0.60
Hair Follicle Dermal Papilla Cells, donor1.CNhs12501.11271-116H2	7.82	3.13	3.13	0.00	0.00
CD14+CD16+ Monocytes, donor3.CNhs13549.11912-125G4	7.76	20.55	3.56	2.10	0.63
Endothelial Cells - Aortic, donor1.CNhs12495.11263-116G3	7.74	3.44	3.44	2.58	0.86
Smooth Muscle Cells - Aortic, donor0.CNhs10838.11210-116A4	7.67	5.58	0.70	0.00	0.70
Mesenchymal Stem Cells - adipose, donor3.CNhs12922.11698-123A6	7.61	6.76	0.00	0.00	0.85
Renal Proximal Tubular Epithelial Cell, donor3.CNhs12120.11676-122H2	7.61	3.58	1.57	0.00	0.45
Smooth Muscle Cells - Brachiocephalic, donor3.CNhs12043.11433-118H2	7.59	7.16	1.29	1.14	1.29
Adipocyte - subcutaneous, donor2.CNhs11371.11336-117F4	7.58	3.79	1.26	0.63	0.63
Preadipocyte - perirenal, donor1.CNhs12065.11469-119C2	7.42	1.48	1.48	0.00	0.00
mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6	7.41	5.33	0.69	0.00	0.46
Renal Epithelial Cells, donor2.CNhs12088.11597-120H4	7.31	5.85	2.92	1.46	0.00
Mesothelial Cells, donor1.CNhs10850.11247-116E5	7.23	6.03	1.21	1.21	0.60
Chondrocyte - de diff, donor2.CNhs11372.11338-117F6	7.02	3.01	1.50	0.50	0.00
Alveolar Epithelial Cells, donor2.CNhs12084.11590-120G6	6.98	5.58	0.70	0.00	0.70
mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2	6.93	2.37	0.17	0.00	0.34
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2.CNhs13822.13425-144D5	6.75	19.61	8.52	1.45	0.80
Fibroblast - Dermal, donor1.CNhs12499.11269-116G9	6.56	4.37	0.31	0.62	0.00
leiomyoma cell line:15425.CNhs11724.10571-108B4	6.53	4.25	0.00	1.31	1.31
leiomyoma cell line:10964C.CNhs11722.10569-108B2	6.52	1.63	0.00	1.09	0.00
Smooth Muscle Cells - Coronary Artery, donor2.CNhs11987.11363-117I4	6.34	6.34	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor1.CNhs11331.11516-119H4	6.32	1.35	0.45	0.00	0.45
Fibroblast - Dermal, donor2.CNhs11379.11346-117G5	6.28	2.28	0.57	0.00	0.00
Smooth Muscle Cells - Carotid, donor3.CNhs12044.11434-118H3	6.28	1.57	1.57	1.57	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2.CNhs13839.13437-144E8	6.23	16.20	7.89	0.42	0.42
Smooth Muscle Cells - Subclavian Artery, donor3.CNhs12048.11438-118H7	6.14	5.26	0.00	0.44	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4.CNhs13097.11838-124H2	6.09	7.24	2.28	1.52	0.76
Endothelial Cells - Microvascular, donor2.CNhs11376.11342-117G1	6.08	3.04	0.00	0.00	0.76
Smooth Muscle Cells - Coronary Artery, donor1.CNhs11088.11286-116I8	6.07	2.63	0.40	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31).CNhs13349.12652-134H6	5.84	5.11	0.73	0.00	0.00
lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3	5.64	1.41	0.70	0.00	0.70
Renal Mesangial Cells, donor1.CNhs11333.11518-119H6	5.42	4.06	1.08	0.54	0.27
leiomyoma cell line:15242A.CNhs11723.10570-108B3	5.19	6.91	1.73	0.00	1.73
Adipocyte - subcutaneous, donor1.CNhs12494.11259-116F8	5.07	2.53	0.00	2.53	0.00
Smooth Muscle Cells - Subclavian Artery, donor1.CNhs11090.11289-117A2	4.96	0.55	1.10	0.00	0.00
Melanocyte - light, donor2.CNhs11383.11351-117H1	4.69	4.69	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor4.CNhs13080.11783-124B1	4.63	9.25	1.54	1.54	0.00
Smooth Muscle Cells - Tracheal, donor1.CNhs11329.11513-119H1	4.63	2.89	0.58	0.58	0.00
Smooth Muscle Cells - Bronchial, donor1.CNhs11328.11512-119G9	4.61	1.79	1.02	0.26	0.26
Smooth Muscle Cells - Pulmonary Artery, donor2.CNhs11989.11365-117I6	4.52	1.13	0.00	0.00	1.13
Mesothelial Cells, donor2.CNhs12197.12156-128G5	4.36	5.23	0.87	0.87	0.00
Smooth Muscle Cells - Aortic, donor2.CNhs11305.11360-117I1	4.26	1.06	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3.CNhs12030.11420-118F7	4.14	1.38	0.00	0.00	0.00
Renal Mesangial Cells, donor3.CNhs12121.11679-122H5	4.01	3.51	0.50	0.00	0.00
Chondrocyte - re diff, donor2.CNhs11373.11339-117F7	3.98	3.18	0.80	0.00	0.80
Endothelial Cells - Vein, donor2.CNhs11377.11344-117G3	3.80	8.54	1.90	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1.CNhs11091.11290-117A3	3.25	2.43	0.20	0.20	1.01
Smooth Muscle Cells - Internal Thoracic Artery, donor3.CNhs12046.11436-118H5	3.17	4.23	1.06	0.00	1.06
Hair Follicle Outer Root Sheath Cells, donor2.CNhs12347.11584-120F9	1.44	5.05	2.17	0.00	0.00
Adipocyte - breast, donor1.CNhs11051.11376-118A8	0.00	0.00	0.00	0.00	0.00

Showing 1 to 889 of 889 entries

0

20

40

60

80

100

120

p1@SMEK1
p2@SMEK1
p3@SMEK1
p4@SMEK1
p5@SMEK1

• Click each plot point to find sample in table

ENCODE TF ChIP-seq peak enrichment analysis Analyst: Erik Arner <br>Summary: For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><br><br>link to source dataset.<br>data

---

No analysis results for this cluster

Details<b>Summary:</b>It includes sequences from the international sequence collaboration, Swiss-Prot, and RefSeq. The RefSeq subset of this file is also available as gene2refseq.<br><br>links to source dataset.<br>human <br>mouse

---

GeneID:	55671
LocusTag:	MSTP033
chromosome:	14
map location:	14q32.12
type of gene:	protein-coding
Symbol from nomenclature authority:	SMEK1
Full name from nomenclature authority:	SMEK homolog 1, suppressor of mek1 (Dictyostelium)
Nomenclature status:	O
Other designations:	serine/threonine-protein phosphatase 4 regulatory subunit 3A
Modification date:	08.01.2012